Status:

RECRUITING

A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

Lead Sponsor:

Celltrion

Conditions:

Refractory or Relapsed Multiple Myeloma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This study is a phase 1/3 study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination with Lenalidomide and Dexamethasone in Patients with Refracto...

Eligibility Criteria

Inclusion

  • \[Main Inclusion Criteria\]
  • Male or female with 18 years of age or older.
  • Patient must have documented multiple myeloma (MM) according to IMWG criteria
  • Patient must have a documented relapsed or refractory disease.
  • Patient must have achieved a response (PR or better based on investigator's determination of response by the IMWG criteria) to at least one prior regimen.
  • Patient must have a PD as defined by the IMWG criteria on or after their last line of therapy.
  • \[Main Exclusion Criteria\]
  • Patient has received daratumumab or any other drug specifically targeting CD38 previously.
  • Patient's disease shows evidence of refractoriness or intolerance to lenalidomide.
  • Patient is known or suspected of not being able to comply with the study protocol (e.g., psychological disorder) or the patient has any condition for which, in the opinion of the investigator, participation would not be in the best interest of the patient (e.g., compromise their well-being) or that could prevent, limit, or confound the protocol-specified assessments.

Exclusion

    Key Trial Info

    Start Date :

    August 12 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 25 2029

    Estimated Enrollment :

    486 Patients enrolled

    Trial Details

    Trial ID

    NCT06952478

    Start Date

    August 12 2025

    End Date

    June 25 2029

    Last Update

    August 15 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Taipei Veterans General Hospital

    Taipei, Beitou District, Taiwan, 11217